Navigation Links
Israeli Colorectal Cancer Expert Unveils Promising Research Dramatically Extending Patients’ Life Expectancy
Date:5/16/2019

A leading cancer expert at Israel’s national hospital has generated cutting-edge research that could potentially extend the life expectancy of colorectal cancer patients worldwide.

Prof. Dan Aderka, the head of the Gastrointestinal Cancer Service at Sheba Medical Center, Tel HaShomer in Israel, and a chief specialist in the field of digestive system oncology, conducted his pioneering research in the Institute of Oncology in collaboration with international associates.

First published in the UK's prestigious The Lancet Oncology Journal, Prof. Aderka’s findings resolve a decade-long debate by providing conclusive data concerning which combinations of biological medicine and chemotherapy have the most successful outcome of extending the life expectancy of colorectal patients.

“Our hope is that this new discovery will mark the dawn of a new era for colorectal cancer patients and extended life expectancies,” said Prof. Aderka. “Essentially, the conclusion of our findings calls into question and unhinges the sequence of the two primary biological medications previously used in treatments for years – Avastin and Erbitux. Now we know that if the appropriate drugs are administered in a specific order, patients’ life expectancy is increased dramatically. This discovery is life-changing.”

Prof. Aderka studied colorectal cancer patients with different types of incurable tumors, classifying them into four groups. In one of the groups, the combination of Avastin with chemotherapy extended life expectancy with a 21-month average, and the combination of Erbitox with chemotherapy increased life expectancy with a 40-month average.

Yet, another focus group within Prof. Aderka’s study that suffered from a different type of colorectal cancer tumor yielded dissimilar results. In this group, Avastin extended life expectancy with a 22-month average, and Erbitox alone only increased life expectancy by an average of 11 months.

“We thought that one treatment across the board would work for all colorectal cancer patients, and because of this, for years we did not know how to use the drugs to their full potential,” said Prof. Aderka. “This research shows that chemotherapy and biological drugs are not a one-size-fits all treatment.”

About Sheba Medical Center, Tel HaShomer
Born together with Israel in 1948, Sheba Medical Center, Tel HaShomer is the largest and most comprehensive medical center in the Middle East. Sheba is the only medical center in Israel that combines an acute care hospital and a rehabilitation hospital on one campus, and it is at the forefront of medical treatments, patient care, research and education. As a university teaching hospital affiliated with the Sackler School of Medicine at Tel-Aviv University, it welcomes people from all over the world indiscriminately. In 2019, Newsweek magazine named Sheba one of the top ten hospitals in the world. To learn more, visit: eng.sheba.co.il.

Read the full story at https://www.prweb.com/releases/israeli_colorectal_cancer_expert_unveils_promising_research_dramatically_extending_patients_life_expectancy/prweb16318032.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. World Renowned Israeli Researcher Shares Groundbreaking Research on the Obesity Epidemic and its Connection to Alzheimer’s Disease
2. In Twist of Fate and Friendship, Israeli Doctor and Palestinian Family Help Save Each Other
3. The Israeli Pharma Company Therapix, is Joined by Five Internationally Renowned Experts, From Israel and the World, in the Field of Psychiatry and Tourette
4. Gamida Cell Announces $4.4 Million Grant from the Israeli Government
5. Oramed to Present at Oppenheimer Annual Israeli Conference
6. Israeli Start-up That Treats Knee Cartilage Injuries Raises $15M for U.S. Pivotal Clinical Trial
7. RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments
8. RegeneRx Receives Israeli Patent for Treating and Repairing Heart Damage
9. Untold News, an American Non-Profit, Awards $10,000 (U.S.) Each to Israeli Inventors of a Cancer Bullet, a Metal Ligament Prosthesis, and a Bendable Plastic Touch Screen Display In First Annual Ceremony
10. CareFusion To Invest $100 Million In Israeli Infusion Pump Maker
11. Alaska Structures Delivers $3.5 Million Dollar Mobile Field Hospital to Israeli Defense Forces to Increase Medical Preparedness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/12/2019)... ... November 12, 2019 , ... The Vinyl Institute (VI), the ... modifiers, announced recipients of its annual health, safety and environmental awards, which are ... the environment at manufacturing facilities throughout the United States and Canada. This year, ...
(Date:11/11/2019)... ... November 11, 2019 , ... ... in Corporate Compliance and Ethics Week. The Society of Corporate Compliance and ... which was scheduled this year from November 3 through 9, 2019. This is ...
(Date:11/11/2019)... , ... November 11, 2019 , ... Over 60 schools ... telehealth service in place. The program is designed to provide virtual mental health care ... storm that struck the region in October of 2018 [1]. , “This initiative by ...
Breaking Medicine Technology:
(Date:11/11/2019)... , ... November 11, 2019 , ... Last year’s expo ... different countries including big box buyers like Costco, Walmart, and GNC. Exhibitors included ... to name a few. , This year, CBD.io and partners, are ...
(Date:11/11/2019)... ... November 11, 2019 , ... Artemis, the ... and urges increased adoption of compliance technology in the wake of the November ... to select retailers in the United States and Canada due to potential contamination ...
(Date:11/11/2019)... ... November 11, 2019 , ... PracticeLink Live! Atlanta Physician Career Fair ... will begin at 5:00 p.m. and continue until 8:00 p.m. A free, optional seminar ... will begin at 6:30 p.m. , Both the career fair and seminar are open ...
(Date:11/9/2019)... ... 2019 , ... Pennsylvania College of Health Sciences, the area’s ... the fourth quarter of the 2018-2019 academic year, the school’s NCLEX scores continue ... College’s annual pass rate for the 2018-2019 academic year was 95.02%, maintaining the ...
(Date:11/9/2019)... ... 2019 , ... On Monday, DOROT was featured in a New York Times ... Yorker who recently faced homelessness. A call to 311 eventually connected her with DOROT, ... new home in an assisted-living facility in Brooklyn. , DOROT alleviates social isolation among ...
Breaking Medicine News(10 mins):